Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Standish Fleming
AddedMar 31, 2024
UpdatedMay 31, 2026
Standish Fleming

Standish Fleming

Board Member, Kemia

Crunchbase

Standish Fleming's Career

Kemia
Kemia

San Diego, CA, US

Board Member· Board
Sanarus Medical
Sanarus Medical

Pleasanton, CA, US

Board Member· Board
Ambit Biosciences
Ambit Biosciences

San Diego, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Standish Fleming's Career

Kemia
Kemia
Series C$100M302001San Diego, CA, US
Board Member· Board

Similar to Kemia

Kimia TherapeuticsKimia TherapeuticsBerkeley, CA, USDrug Developmentest. 2023Kimia TherapeuticsBerkeley, CA, US · est. 2023

Empowering better medicine development through deep data insights and innovative tools.

Series A · $55M12
Kiniksa PharmaceuticalsKiniksa PharmaceuticalsLexington, KY, USPharmaceuticalsest. 2015Kiniksa PharmaceuticalsLexington, KY, US · est. 2015

Kiniksa Pharmaceuticals: A global, clinical-stage biopharma firm developing therapies for debilitating diseases.

Public · $400M220
ComplexaComplexaPittsburgh, PA, USTherapeuticsest. 2008ComplexaPittsburgh, PA, US · est. 2008

Complexa, Inc.: A biopharmaceutical firm innovating therapies for inflammatory and metabolic diseases.

Public · $86.9M7
KinDex PharmaceuticalsKinDex PharmaceuticalsSeattle, WA, USTherapeuticsest. 2009KinDex PharmaceuticalsSeattle, WA, US · est. 2009

KinDex Pharmaceuticals develops novel therapeutics for metabolic disorder treatment.

Angel · $5.8M10
Sanarus Medical
Sanarus Medical
$70.9M01999Pleasanton, CA, US
Board Member· Board

Leadership at Sanarus Medical

Farah ChampsiFarah ChampsiBoard Member
Alan KaganovAlan KaganovBoard Member

Similar to Sanarus Medical

SaranasSaranasHouston, TX, USMedical Devicesest. 2011SaranasHouston, TX, US · est. 2011

Saranas: Houston-based medical device firm, specializing in internal bleeding detection during catheterization since 2011.

Series B · $29.2M7
Encapsule MedicalEncapsule MedicalSan Francisco, CA, USMedical Devicesest. 1998Encapsule MedicalSan Francisco, CA, US · est. 1998

Encapsule Medical: A San Francisco-based company specializing in minimally invasive breast biopsy and tissue removal devices.

Series C · $32.9M30
MammotomeMammotomeCincinnati, OH, USMedical Devicesest. 1995MammotomeCincinnati, OH, US · est. 1995

Mammotome manufactures medical products, specializing in vacuum-assisted biopsy systems for breast cancer detection.

Public · $14M525
Rubicor MedicalRubicor MedicalRedwood City, CA, USMedical Devicesest. 1998Rubicor MedicalRedwood City, CA, US · est. 1998

Rubicor Medical manufactures advanced, non-invasive breast biopsy devices for minimally invasive procedures.

Series C · $32.9M30
Ambit Biosciences
Ambit Biosciences
$215.7M02000San Diego, CA, US
Board Member· Board

Leadership at Ambit Biosciences

Kevin KinsellaKevin KinsellaFounder
Isai PeimerIsai PeimerBoard Member
M. Scott SalkaM. Scott SalkaCEO

People Similar to Standish Fleming

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao